Prostate Cancer: Screening
The question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2026 to Question 11285, and with reference to the report entitled UK National Screening Committee, Screening for prostate cancer, whether his Department is taking steps to estimate the cost of identifying new BRCA2 variant carriers.
Answered by Department of Health and Social Care
The Department estimates that there are approximately 1,500 men currently known to have both a BRCA2 gene variant and a family history of breast, pancreatic, ovarian, or prostate cancer who will be eligible for the targeted prostate cancer screening programme. The Department has not estimated the costs of identifying additional BRCA2 variant carriers, as the UK National Screening Committee, which advises the Government on all screening related matters, did not recommend proactively identifying BRCA2 carriers.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →